Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma

Cancer Investigation

Volumn 26, Issue 10, 2008, Pages 977-983

  Jia, Li ^a   Xu, Henggui ^a   Zhao, Yongfu ^a   Jiang, Lili ^a   Yu, Jingda ^a   Zhang, Jianing ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

CD147; MDR1; MMP11

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CD147 ANTIGEN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; MULTIDRUG RESISTANCE PROTEIN 1; STROMELYSIN 3; VINCRISTINE;

ANTIGEN EXPRESSION; ARTICLE; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANTIGENS, CD147; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA PRIMERS; DRUG RESISTANCE, MULTIPLE; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 11; NEOPLASM INVASIVENESS; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, NEOPLASM;

EID: 57749182007     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802072723     Document Type: Article

References (34)

1. Kerbel, R.; Korczak, S.; Lagarde, B.A. Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv Cancer Res 1990, 5, 87-132.
2. Su, Z.Z.; Austin, V.N.; Zimmer, S.G.; Fisher, P.B. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Oncogene 1993, 8, 1211-1219.
3. Yang, J.M.; Xu, Z.; Wu, H.; Zhu, H.; Wu, X.; Hait, W.N. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res 2003, 1, 420-427.
4. Zou, W.; Zhu, H.; Wu, X. Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells. Cancer Lett 2006, 248, 211-218.
5. Li, Q.Q.; Wang, W.J.; Xu, J.D.; Cao, X.X.; Chen, Q.; Yang, J.M.; Xu, Z.D. Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells. Cancer Sci 2007, 98, 1064-1069.
6. Nelson, A.R.; Fingleton, B.; Rothenberg, M.L. Matrisian, L.M. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000, 18, 1135-1149.
7. Illemann, M.; Bird, N.; Majeed, A.; Sehested, M.; Laerum, O.D.; Lund, L.R.; Dano, K.; Nielsen, B.S. MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases. Mol Cancer Res 2006, 4, 293-302.
8. Rio, M.C. From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation. Biochimie 2005, 87, 299-306.
9. Chan, H.S.; Thorner, P.S.; Haddad, G.; Ling, V. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 1990, 8, 689-704.
10. Verrelle, P.; Meissonnier, F.; Fonck, Y.; Feillel, V.; Dionet, C.; Kwiatkowski, F.; Plagne, R.; Chassagne, J. Clinical relevance of immunohistochemical detection of multidrug resistance Pglycoprotein in breast carcinoma. J Natl Cancer Inst 1991, 83, 111-116.
11. Yang, J.M.; Yang, G.Y.; Medina, D.J.; Vassil, A.D.; Liao, J.; Hait, W.N. Treatment of multidrug resistant (MDR1) murine leukemia with P-glycoprotein substrates accelerates the course of the disease. BBRC 1999, 266, 167-173.
12. Weinstein, R.S.; Jakate, S.M.; Dominguez, J.M.; Lebovitz, M.D.; Koukoulis, G.K.; Kuszak, J.R.; Klusens, L.F.; Grogan, T.M.; Saclarides, T.J.; Roninson, I.B.; Coon, J.S. Relationship of the expression of themultidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 1991, 51, 2720-2726.
13. Ding, S.; Chamberlain, M.; McLaren, A.; Goh L.; Duncan, I.; Wolf, C.R. Cross-talk between signalling pathways and the multidrug resistant protein MDR-1. Br J Cancer 2001, 85, 1175-1184.
14. Davidson, B.; Givant-Horwitz, V.; Laranovici, P.; Risberg, B.; Nesland, J.M.; Trope, C.G.; Schaefer, E.; Reich, R. Matrix rnetalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma. Clin Exp Metastasis 2002, 20, 621-631.
15. Lim, M.; Martinez, T.; Jablons, D.; Cameron, R.; Guo, H.; Toole, B.; Li, J.D.; Basbaum, C. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett 1998, 441, 88-92.
16. Khunkeawla, P.; Moonsom, S.; Staffler, G.; Kongtawelert, P.; KasinrerK, W. Engagement of CD147 molecule-induced cell aggregation through the activation of protein kinases and reorganization of the cytoskeleton. Immunobiol 2001, 203, 659-669.
17. Jia, L.; Wang, H.; Qu, S.; Miao, X.; Zhang, J. CD147 Regulates Vascular Endothelial Growth Factor-A Expression, Tumorigenicity, and Chemosensitivity to Curcumin in Hepatocellular Carcinoma. IUBMB Life 2008, 60, 57-63.
18. Misra, S.; Ghatak, S.; Zoltan-Jones, A.; Toole, B.P. Regulation of multidrug resistance in cancer cells by hyaluronan. J Biol Chem 2003, 278, 25285-25288.
19. Muramatsu, T.; Miyauchi, T. Basigin (CD147): a multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion. Histol Histopathol 2003, 18, 981-987.
20. Yan, L.S.; Zucker, B.P. Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb Haemos 2005, 93, 199-204.
21. Kanekura, T.; Chen, X.; Kanzaki, T. Basigin (CD147) is system with an improved hairpin and its significant expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 2002, 99, 520-528.
22. Basset, P.; Bellocq, J.P.;Wolf, C.; Stoll, I.; Hutin, P.; Limacher, J.M.; Podhajcer, O.L.; Chenard, M.P.; Rio, M.C.; Chambon, P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990, 348, 699-704.
23. Delebecq, T.J.; Porte, H., Zerimech, F.; Copin, M.C.; Gouyer, V. Dacquembronne, E. Overexpression level of stromelysin 3 is related to the lymph node involvement in nonsmall cell lung cancer. Clin Cancer Res 2000, 6, 1086-1092.
24. Deng, H.; Guo, R.F.; Li, W.M.; Zhao, M.; Lu, Y.Y. Matrix metalloproteinase 11 depletion inhibits cell proliferation in gastric cancer cells. BBRC 2005, 14, 274-281.
25. Noel, A.; Boulay, A.; Kebers, F.; Kannan, R.; Hajitou, A.; CalbergBacq, C.M. Demonstration in vivo that stromelysin-3 functions through its proteolytic activity. Oncogene 2000, 19, 1605-1612.
26. Sameshima, T.; Nabeshima, K.; Toole, B.P.; Yokogami, K.; Okada, Y.; Goya, T.; Koono, M.; Wakisaka, S. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membranetype matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett 2000, 157, 177-184.
27. Jiang, J.L.; Zhou, Q.; Yu, M.K.; Ho, L.S.; Chen, Z.N.; Chan, H.C. The involvement of HAb18G/CD147 in regulation of store-operated calcium entry and metastasis of human hepatoma cells. J Biol Chem 2001, 276, 46870-46877.
28. Jia, L.; Cao, J.; Wei, W.; Wang, S.; Zuo, Y.; Zhang, J. CD147 depletion down-regulates matrix metalloproteinase-11, vascular endothelial growth factor-A expression and the lymphatic metastasis potential of murine Hepatocarcinoma Hca-F IJBCB 2007, 39, 2135-2142.
29. Osborn, M.T.; Chambers, T.C. Role of the stress-activated/c-Jun NH2-terminal protein kinase pathway in the cellular response to Adriamycin and other chemotherapeutic drugs. J Biol Chem 1996, 271, 30950-30955.
30. Yang, J.M.; Vassil, A.D.; Hait, W. N. Activation of phospholipase C induces the expression of the multidrug resistance (MDR1) gene through the Raf-MAPK pathway. Mol Pharmacol 2001, 60, 674-680.
31. Huang, C.; Jacobson, K.; Schaller, M.D. MAP kinases and cell mobility. J Cell Sci 2004, 117, 4619-4628.
32. Brauchle, M.; Gluck, D.; Padova, F.D.; Han, J.H.; Gram, H. Independent role of p38 and ERK1/2 mitogen-activated kinases in the upregulation of matrix metalloproteinase-1. Exp Cell Res 2000, 258, 135-144.
33. Xu, H.Y.; Qian, A.R.; Shang, P.; Xu, J.; Kong, L.M.; Bian, H.J.; Chen, Z.N. siRNA targeted against HAb18G/CD147 inhibits MMP-2 secretion, actin and FAK expression in hepatocellular carcinoma cell line via ERK1/2 pathway. Cancer Lett 2007, 18, 336-344.
34. Gabison, E.E.; Hoang-Xuan, T.; Mauviel, A. Menasshi, S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 2005, 87, 361-368.